Characterization of a new inhalable thymopentin formulation

International Journal of Pharmaceutics

Volumn 375, Issue 1-2, 2009, Pages 1-7

  Wang, Lei ^a   Zhang, Yu ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Dry powder inhalation; Leucine; Pulmonary drug delivery; Spray drying; Thymopentin

Indexed keywords

BULKING AGENT; DISPERSANT; LACTOSE; LEUCINE; MANNITOL; POLOXAMER; THYMOPENTIN;

AEROSOL; ARTICLE; CONTROLLED STUDY; DENSITY; DRUG FORMULATION; DRY POWDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHALATIONAL DRUG ADMINISTRATION; LASER DIFFRACTION; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THERMOGRAVIMETRY;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INHALATION; AEROSOLS; EXCIPIENTS; LACTOSE; LEUCINE; MANNITOL; PARTICLE SIZE; POLOXAMER; POWDERS; THYMOPENTIN;

EID: 65749112548     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.03.020     Document Type: Article

References (33)

1. Adjei A.L., and Gaupta P.K. Inhalation Delivery of Delivery of Therapeutic Peptides and Proteins (1997), Marcel Dekker Inc., New York, Basel, Hong Kong
2. Adler M., Unger M., and Lee G. Surface composition of spray dried particles of bovine serum albumin/trehalose/surfactant. Pharm. Res. 17 (2000) 863-870
3. Arakawa T., Pretrelski S.J., Kenney W.C., and Carpenter J.F. Factors affecting short-term and long-term stabilities of proteins. Adv. Drug Deliv. Rev. 10 (1993) 1-28
4. Bosquillon C., Lombry C., Préat V., and Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J. Control. Release 70 (2001) 329-339
5. Bosquillon C., Rouxhet P.G., Ahimou F., Simonc D., Culotd C., Préata V., and Vanbevera R. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J. Control. Release 99 (2004) 357-367
6. Byron P.R. Determinants of drug and polypeptide bioavailability from aerosols delivered to the lung. Adv. Drug Deliv. Rev. 5 (1990) 107-132
7. Carstensen J.T. Pharmaceutical Principles of Solid Dosage Forms (1993), Technomic Publishing, Lancaster, PA p. 27
8. Chew N.Y., Shekunov B.Y., Tong H.H., Chow A.H., Savage C., Wu J., and Chan H.K. Effect of amino acids on the dispersion of disodium cromoglycate powders. J. Pharm. Sci. 94 (2005) 2289-2300
9. Chougule M.B., Padhi B.K., Jinturkar K.A., and Misra A. Development of dry powder inhalers. Recent Patents Drug Deliv. Formulation 1 (2007) 11-21
10. Clumeck N., Cran S., Van de perre P., Mascart-Lemone F., Duchateau J., and Bolla K. Thymopentin treatment in AIDS and pre-AIDS patients. Immunol. Res. 4 (1985) 58-62
11. Corrigan O.I. Thermal analysis of spray dried products. Thermochim. Acta 248 (1995) 245-258
12. Edwards, D.A., Caponetti, G., Hrkach, J.S., Lotan, N., Anes, J., Ben-Jebria, A.A., Langer, R.S., 2005. Aerodynamically light particles for pulmonary drug delivery. US Patent 6,977,087. 20 December.
13. Elversson J., and Millqvist-Fureby A. In situ coating-an approach for particle modification and encapsulation of proteins during spray-drying. Int. J. Pharm. 323 (2006) 52-63
14. Gliniski J., Chavepeyer G., and Platten J.K. Surface properties of aqueous solutions of l-leucine. Biophys. Chem. 84 (2000) 99-103
15. Goldstein G., Scheid M.P., Boyse E.A., Schlesinger D.H., and Van Wauwe J. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 204 (1979) 1309-1310
16. Hinds W.C. Uniform particle motion. In: Hinds W.C. (Ed). Aerosol Technology-Properties, Behavior and Measurement of Airborne Particles (1999), Wiley & Sons, New York 42-74
17. Johnson K.A. Preparation of peptide and protein powders for inhalation. Adv. Drug Deliv. Rev. 26 (1997) 3-15
18. Larhrib H., Martin G.P., Marriott C., and Prime D. The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int. J. Pharm. 257 (1995) 283-296
19. Maa Y.-F., Nguyen P.-A., Andya J.D., Dasovich N., Sweeney T.D., Shire S.J., and Hsu C.C. Effect of spray drying and subsequent processing conditions on residual moisture content and physicalbiochemical stability of protein inhalation powders. Pharm. Res. 15 (1998) 768-775
20. Maa Y.-F., Nguyen P.-A., and Hsu C.C. Spray-drying of air-liquid interface sensitive recombinant human growth hormone. J. Pharm. Sci. 87 (1998) 152-159
21. Masters K. Applications in the pharmaceutical-biochemical industry. Spray Drying Handbook. 4th Ed. (1985), George Godwin, Harlow Essex, England pp. 625-644
22. Najafabadi A.R., Gilani K., Barghi M., and Rafiee-Tehrani M. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with l-leucine. Int. J. Pharm. 285 (2004) 97-108
23. Prime D., Atkins P.J., Slater A., and Sumby B. Powder inhalers. Adv. Drug Deliv. Rev. 26 (1997) 51-58
24. Rabbani N.R., and Seville P.C. The influence of formulation components on the aerosolisation properties of spray-dried powders. J. Control. Release 110 (2005) 130-140
25. Ranade M.B. Adhesion and removal of fine particles on surfaces. Aerosol Sci. Technol. 7 (1987) 161-176
26. Raula J., Kurkela J.A., Brown D.P., and Kauppinen E.I. Study of the dispersion behaviour of l-leucine containing microparticles synthesized with an aerosol flow reactor method. Powder Technol. 177 (2007) 125-132
27. Seville P.C., Learoyd T.P., Li H.-Y., Williamson I.J., and Birchall J.C. Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Technol. 178 (2007) 40-50
28. Shoyele S.A., and Cawthorne S. Particle engineering techniques for inhaled biopharmaceuticals. Adv. Drug Deliv. Rev. 58 (2006) 1009-1029
29. Singh V.K., Biswas S., Mathur K.B., Haq W., Garg S.K., and Agarwal S.S. Thymopentin and splenopentin as immunomodulators. Immunol. Res. 17 (1998) 345-368
30. Ståhl K., Claesson M., Lilliehorn P., Lindén H., and Bäckström K. The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation. Int. J. Pharm. 233 (2002) 227-237
31. Steckel H., and Brandes H.G. A novel spray-drying technique to produce low density particles for pulmonary delivery. Int. J. Pharm. 278 (2004) 187-195
32. Vanbever R., Mintzes J.D., Wang J., Nice J., Chen D., Batycky R., Langer R., and Edwards D.A. Formulation and physical characterization of large porous particles for inhalation. Pharm. Res. 16 (1999) 1735-1742
33. Zeng X.-M., Martin G.P., and Marriott C. Particle Interactions in Dry Powder Formulations for Inhalation. 1st Ed. (2001), Taylor and Francis, London